Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Huben

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
American Journal of Clinical Pathology|October 1, 1989
Renal cortical tumors. Cytogenetic characterizationP Dal Cin, J Gaeta, R Huben, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of 1-(2-[2-(4-pyridyl)-2-imidazoline-1-yl]-ethyl)-3-(4-carboxy-phenyl) urea (CGP 15720A)P J Creaven, S Madajewicz, L Pendyala, et al.
The Journal of Urology|December 1, 1985
Characterization of a renal cell carcinoma cell line suitable as a target for immunological studies in vitro and in the nu/nu mouseM H Goldrosen, R Huben, G A Miller, et al.
Urology|September 1, 1985
Whole bladder photodynamic therapy for transitional cell carcinoma of bladderU O Nseyo, T J Dougherty, D G Boyle, et al.
Cancer Genetics and Cytogenetics|January 15, 1986
Rearrangement of chromosome 3 in renal cell carcinomaM A Yoshida, K Ohyashiki, H Ochi, et al.
Cancer Research|April 1, 1986
Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinomaM A Yoshida, K Ohyashiki, H Ochi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Translational studies of glutathione in bladder cancer cell lines and human specimensL Pendyala, S Velagapudi, K Toth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809)P J Creaven, S Madajewicz, J W Cowens, et al.
Journal of Biological Response Modifiers|October 1, 1990
Initial clinical trial of the macrophage activator muramyl tripeptide-phosphatidylethanolamine encapsulated in liposomes in patients with advanced cancerP J Creaven, J W Cowens, D E Brenner, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
American Journal of Clinical Pathology|October 1, 1989
Renal cortical tumors. Cytogenetic characterizationP Dal Cin, J Gaeta, R Huben, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of 1-(2-[2-(4-pyridyl)-2-imidazoline-1-yl]-ethyl)-3-(4-carboxy-phenyl) urea (CGP 15720A)P J Creaven, S Madajewicz, L Pendyala, et al.
The Journal of Urology|December 1, 1985
Characterization of a renal cell carcinoma cell line suitable as a target for immunological studies in vitro and in the nu/nu mouseM H Goldrosen, R Huben, G A Miller, et al.
Urology|September 1, 1985
Whole bladder photodynamic therapy for transitional cell carcinoma of bladderU O Nseyo, T J Dougherty, D G Boyle, et al.
Cancer Genetics and Cytogenetics|January 15, 1986
Rearrangement of chromosome 3 in renal cell carcinomaM A Yoshida, K Ohyashiki, H Ochi, et al.
Cancer Research|April 1, 1986
Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinomaM A Yoshida, K Ohyashiki, H Ochi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Translational studies of glutathione in bladder cancer cell lines and human specimensL Pendyala, S Velagapudi, K Toth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809)P J Creaven, S Madajewicz, J W Cowens, et al.
Journal of Biological Response Modifiers|October 1, 1990
Initial clinical trial of the macrophage activator muramyl tripeptide-phosphatidylethanolamine encapsulated in liposomes in patients with advanced cancerP J Creaven, J W Cowens, D E Brenner, et al.
Pageof 3